What is Solid-Phase Peptide Synthesis?
Solid-Phase Peptide Synthesis (SPPS) is the standard method used for the production of synthetic peptide compounds for research applications. Developed by Robert Bruce Merrifield in the 1960s — work for which he was awarded the Nobel Prize in Chemistry in 1984 — SPPS revolutionised the ability to produce defined peptide sequences at laboratory scale with high reproducibility.
The central principle of SPPS is the stepwise assembly of amino acid chains while one end of the growing chain is anchored to an insoluble solid support (resin). This allows unreacted reagents and by-products to be washed away between each coupling step, simplifying purification and enabling automation.
The SPPS Process
- Resin Selection
The synthesis begins with the selection of an appropriate solid support resin. The resin determines the C-terminal chemistry of the final peptide and influences the cleavage conditions required at the end of synthesis.
- Protecting Group Chemistry
Amino acids contain multiple reactive groups. To ensure that coupling reactions occur only at the intended positions, all reactive side chains must be temporarily protected using chemical blocking groups. The two principal SPPS strategies are:
Fmoc (9-fluorenylmethoxycarbonyl): Base-labile N-terminal protection; the most widely used strategy in modern research peptide synthesis
Boc (tert-butyloxycarbonyl): Acid-labile protection; used for specific synthesis requirements
- Chain Assembly
Amino acids are added one at a time to the growing chain in a defined sequence. Each coupling step involves:
- Deprotection of the N-terminal amine on the resin-bound chain
- Activation of the incoming amino acid
- Coupling of the activated amino acid to the deprotected chain terminus
- Washing to remove excess reagents
This cycle is repeated for each amino acid in the target sequence.
- Cleavage and Deprotection
Once the full sequence has been assembled, the completed peptide is cleaved from the resin using an appropriate cleavage reagent (typically a trifluoroacetic acid mixture for Fmoc synthesis). This simultaneously removes the remaining side chain protecting groups, yielding the crude free peptide.
- Purification
The crude peptide is purified using preparative High-Performance Liquid Chromatography (HPLC) to remove synthesis by-products, truncated sequences, and other impurities. Purity is verified by analytical HPLC and confirmed by mass spectrometry.
- Lyophilisation
The purified peptide solution is freeze-dried (lyophilised) to produce a stable, dry powder suitable for long-term storage and distribution as a research reference material.
Quality Verification
Every batch produced by SPPS is characterised by analytical HPLC (for purity) and mass spectrometry (for sequence identity confirmation). Results are documented in the Certificate of Analysis (COA) accompanying each batch.
